• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Our people > Leadership > Policy Advocacy
Rachel Cohen

Rachel M. Cohen

Senior Advisor, Global Policy Advocacy, DNDi

  • @rachelmcohen72

Rachel M. Cohen joined DNDi as the Director of DNDi North America in January 2011 and led the North America office until 2023. She is now Senior Advisor, Global Policy Advocacy.

Rachel has worked in the global health and humanitarian field for more than 20 years. Prior to joining DNDi, she worked for Doctors Without Borders/Médecins Sans Frontières (MSF) from 1999-2010. She served as Head of Mission for MSF in South Africa and Lesotho for four years, overseeing HIV/AIDS, tuberculosis, sexual violence, and migrant health programmes. Before working for MSF in the field, Rachel held numerous positions with MSF in New York, including U.S. Director for MSF’s Access Campaign, where she directed policy advocacy activities in the U.S. related to drug pricing, intellectual property, and medical innovation for neglected diseases. From 2009-2015, she also served on the Board of Directors of MSF’s Operational Center in Brussels.

Prior to working with MSF, Rachel was the Director of Foundation & Corporate Giving at Housing Works, the largest grassroots AIDS service organization in the U.S., and before that, served as Program Coordinator for the U.S.+Cuba Medical Project, where she directed medical aid, educational, and advocacy programmes.

Rachel has published numerous articles in peer-reviewed journals, co-authored dozens of reports, and been quoted extensively in the media. She is currently a member of the Steering Committee of the Global Health Technologies Coalition.

Rachel earned her Master’s in Public Policy with a Certificate in Health and Health Policy from Princeton University’s School of Public and International Affairs.

Featured news & publications

Loading...
  • Paving the way for affordable and equitable liposomal amphotericin B access worldwide
  • Can non-profits beat antibiotic resistance and soaring drug costs?
  • Biotech leader Delali Attiogbe Attipoe joins DNDi as North America Director
  • There will be new COVID-19 drugs. Will we use them to save the most lives?
  • To counter Omicron, Covid-19 treatments must be cheap and accessible
  • Sommet sur le Covid-19 en marge de l’AG de l’ONU: comment changer de paradigme?
  • Will science deliver needed therapeutics for COVID-19—and how can equitable access be ensured?
  • Will science deliver needed therapeutics for COVID-19 – and how can equitable access be ensured?
  • Un monde à deux vitesses
  • Suspender las patentes no resolverá la escasez de vacunas

Featured events

Loading...
  • Ongoing pandemic (tuberculosis) response and future pandemic preparedness – How to make synergy
  • Roundtable: How can disclosing clinical trial costs increase access to medical products?
  • MSF Access Campaign roundtable: How can disclosing clinical trial costs increase access to medical products?
  • Online MSF webinar: Global access to medicines and vaccines for COVID-19
  • Affordable Medicines Now

Our global footprint

Loading...
Doctors talking with patient in hospital

DNDi DRC

Female healthcare worker taking care of a little girl

DNDi Eastern Africa

DNDi Japan

Female patient discussing with doctor

DNDi Latin America

Female doctor with a patient in a hospital

DNDi North America

Community worker talking with people in a rural village

DNDi South Asia

Malaysian doctor talking with a man in a hospital

DNDi South-East Asia

Two people speaking in an office

DNDi Switzerland

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License